Dysregulated JAK/STAT signalling leads to an increase in survival and proliferation of various types of cancer cells, suggesting that tubulosine could decrease viability only in cancer cells harbouring constitutively active JAK3 signalling. This evidence concerns the gene JAK3 and cancer.